Platinum Investment Management LTD Pacific Biosciences Of California, Inc. Transaction History

Platinum Investment Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$19.26 - $30.08 $5.03 Million - $7.86 Million	-261,242 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$26.38 - $51.15 $4.72 Million - $9.16 Million	-179,018 Reduced 40.66%	261,242 $8.7 Million
Q4 2020 Feb 12, 2021	SELL	$10.5 - $28.5 $2.71 Million - $7.34 Million	-257,653 Reduced 36.92%	440,260 $11.4 Million
Q3 2020 Nov 13, 2020	SELL	$3.61 - $9.87 $572,592 - $1.57 Million	-158,613 Reduced 18.52%	697,913 $6.89 Million
Q2 2020 Aug 06, 2020	BUY	$2.65 - $4.03 $945,599 - $1.44 Million	356,830 Added 71.41%	856,526 $2.96 Million

Q1 2020 May 15, 2020	BUY	$2.36 - $5.26 $595,241 - $1.33 Million	252,221 Added 101.92%	499,696 $1.53 Million
Q4 2019 Feb 13, 2020	BUY	$4.6 - $5.57 $1.14 Million - $1.38 Million	247,475 New	247,475 $1.27 Million

293

253M

1.42M

1.18M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $308M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.